 | BiogenICO Biogen is a startup aiming to extend human life expectancy. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
OpenWhat is Biogen
MARKET OVERVIEW
Two billion potential customers. There is no competition. Nobody today has managed to extend human life. The aging is related to many other diseases.
Opportunity
great advances in this field, lack of capital for research, possible agreements with renowned scientists.
The Problem
Today we have been able to extend the life of mice by 40%. Now it is necessary to carry out tests in humans, but death is not considered a disease, so you can not perform tests in humans just for the sake of prolonging life.
The solution
Experiment with humans who have degenerative diseases, but for that it is necessary to reach agreements with hospitals and renowned scientists who need these funds to complete their research.
Thanks to the Blockchain technology, we can collect those funds and have small investors exchange tokens for ours, which will then be used to verify that the address of the electronic.
TOKEN HTER
The HTER tokens are tokens compatible with ERC-20 distributed in the Ethereum blockchain in accordance with a related ERC-20 intelligent contract (the "HTER Tokens").
DetailsPre-sales: Mar 01, 2019 - Mar 31, 2019Public sales: Apr 01, 2019 - Sep 30, 2019 Token supply: 2,000,000,000 Total tokens for sale: 5,000,000,000 HTER Soft cap: 3,000,000 USD Hard cap: 400,000,000 USD LegalBlockchain Platform: EthereumRegistration country: Ireland Registration year: 2018 Office address: Lower Ground Floor, 64 Lower Mount Street, Dublin 2 | Token infoTicker: HTERType: Utility-token Token price in USD: 1 HTER= 0.06399 USD Token price in ETH: 1 HTER = 0.0004 ETH Accepted currencies: ETH Bonus program: Token Price: 01.03-31.03 - 0.0004 ETH 01.04-31.05 - 0.00045 ETH 01.06-31.07 - 0.00048 ETH 01.08-31.08 - 0.00051 ETH 01.09-30.09 - 0.00054 ETH Token distribution: 40% - Token Sale 9% - Executives, Workers and Collaborators 51% - Company Funds allocation: 70% - R&D, Operational 20% - Marketing 5% - Legal and Accounting 5% - Miscellaneous |
Biogen Roadmap
ICO launch
Final ICO
Hter Token distribution to buyers
List on Exchange
Publication of agreements and relevant news
Annual report of the company
Project team
Advisors
Social media
